AMERICAN SHARED HOSPITAL SERVICES (NYSE MKT:AMS), a
leading provider of turnkey technology solutions for advanced
radiosurgical and radiation therapy services, announced today the
delivery of the superconducting synchrocyclotron proton accelerator—the
key element of the MEVION S250™ proton therapy system—to the dedicated
proton center now under development at the UF Health Cancer Center at
Orlando Health.
AMS Chairman and Chief Executive Officer Ernest A. Bates, M.D., said,
"The delivery of the synchrocyclotron for the MEVION S250 is a major
step forward in the development of the proton center at the UF Health
Cancer Center at Orlando Health. As Central Florida’s most advanced
cancer center, the UF Health Cancer Center at Orlando Health is the
first hospital in the Central Florida region to install a proton therapy
system. Construction of the proton center is moving forward, and we
expect patient treatments to begin in the first quarter of 2016."
About AMS
American Shared Hospital Services provides turnkey technology solutions
for advanced radiosurgical and radiation therapy services. AMS is the
world leader in providing Gamma Knife radiosurgery equipment, a
non-invasive treatment for malignant and benign brain tumors, vascular
malformations and trigeminal neuralgia (facial pain). The Company also
offers the latest IGRT and IMRT systems, as well as its proprietary
Operating Room for the 21st CenturySM concept. AMS owns a
common stock investment in Mevion Medical Systems, Inc., developer of
the compact MEVION S250 Proton Therapy System.
Safe Harbor Statement
This press release may be deemed to contain certain forward-looking
statements with respect to the financial condition, results of
operations and future plans of American Shared Hospital Services, which
involve risks and uncertainties including, but not limited to, the risks
of the Gamma Knife and radiation therapy businesses, the risks of
developing The Operating Room for the 21st Century program, the risks of
investing in a development-stage company, Mevion Medical Systems, Inc.,
and the risks of the timing, financing, and operations of the Company’s
proton therapy business. Further information on potential factors
that could affect the financial condition, results of operations and
future plans of American Shared Hospital Services is included in the
filings of the Company with the Securities and Exchange Commission,
including the Company's Annual Report on Form 10-K and Form 10-K/A for
the year ended December 31, 2013, the Form 10-Q for the quarter ended
March 31, 2014 and the Form 10-Q and Form 10-Q/A for the quarter ended
June 30, 2014, and the definitive Proxy Statement for the Annual Meeting
of Shareholders held on June 10, 2014.
Copyright Business Wire 2014